FP

Flagship Pioneering Portfolio holdings

AUM $268M
This Quarter Return
+45.11%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$6.24B
AUM Growth
+$6.24B
Cap. Flow
-$193M
Cap. Flow %
-3.09%
Top 10 Hldgs %
99.02%
Holding
12
New
1
Increased
3
Reduced
1
Closed
–

Top Buys

1
SANA icon
Sana Biotechnology
SANA
$1.15B
2
RUBY
Rubius Therapeutics, Inc
RUBY
$5.57M
3
KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
$1.74M
4
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
$1.39M

Top Sells

1
MRNA icon
Moderna
MRNA
$1.35B

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNA icon
1
Moderna
MRNA
$9.37B
$2.7B 43.16%
20,581,016
-10,290,508
-33% -$1.35B
SANA icon
2
Sana Biotechnology
SANA
$777M
$1.15B 18.35%
+34,239,018
New +$1.15B
RUBY
3
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.02B 16.34%
38,506,526
+210,000
+0.5% +$5.57M
MCRB icon
4
Seres Therapeutics
MCRB
$166M
$302M 4.84%
14,673,973
– –
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$246M 3.95%
23,030,069
+130,000
+0.6% +$1.39M
SGTX
6
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$232M 3.71%
10,370,369
– –
FHTX icon
7
Foghorn Therapeutics
FHTX
$286M
$167M 2.68%
12,674,120
– –
KLDO
8
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$159M 2.54%
19,575,710
+215,000
+1% +$1.74M
DNLI icon
9
Denali Therapeutics
DNLI
$2.23B
$156M 2.5%
2,730,263
– –
AXLA
10
DELISTED
Axcella Health Inc. Common Stock
AXLA
$59.7M 0.96%
12,548,414
– –
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$39.3M 0.63%
2,607,303
– –
SYRS
12
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$22M 0.35%
2,938,494
– –